Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$1.0 - $1.39 $41,106 - $57,137
-41,106 Reduced 80.42%
10,008 $11,000
Q3 2023

Nov 14, 2023

SELL
$1.22 - $4.83 $70,952 - $280,903
-58,158 Reduced 53.22%
51,114 $62,000
Q2 2023

Aug 14, 2023

BUY
$2.95 - $4.44 $322,352 - $485,167
109,272 New
109,272 $427,000
Q4 2022

Feb 14, 2023

BUY
$2.73 - $3.7 $171,894 - $232,970
62,965 New
62,965 $183,000
Q1 2022

May 17, 2022

SELL
$3.58 - $4.98 $89,321 - $124,251
-24,950 Closed
0 $0
Q4 2021

Feb 15, 2022

BUY
$4.17 - $7.09 $104,041 - $176,895
24,950 New
24,950 $128,000
Q2 2021

Aug 16, 2021

SELL
$6.69 - $9.0 $157,669 - $212,112
-23,568 Closed
0 $0
Q1 2021

May 18, 2021

SELL
$8.26 - $11.4 $447,964 - $618,256
-54,233 Reduced 69.71%
23,568 $194,000
Q4 2020

Feb 17, 2021

SELL
$8.21 - $18.59 $123,601 - $279,872
-15,055 Reduced 16.21%
77,801 $674,000
Q3 2020

Nov 17, 2020

BUY
$11.33 - $19.81 $340,149 - $594,735
30,022 Added 47.78%
92,856 $1.69 Million
Q2 2020

Aug 17, 2020

BUY
$4.2 - $15.45 $199,668 - $734,493
47,540 Added 310.84%
62,834 $705,000
Q1 2020

May 15, 2020

SELL
$3.38 - $10.63 $26,455 - $83,201
-7,827 Reduced 33.85%
15,294 $65,000
Q4 2019

Feb 14, 2020

SELL
$5.74 - $7.42 $154,922 - $200,265
-26,990 Reduced 53.86%
23,121 $169,000
Q3 2019

Nov 14, 2019

BUY
$4.68 - $7.42 $234,519 - $371,823
50,111 New
50,111 $362,000
Q2 2019

Aug 15, 2019

SELL
$4.67 - $5.88 $68,560 - $86,324
-14,681 Closed
0 $0
Q1 2019

May 16, 2019

SELL
$4.19 - $5.25 $374,552 - $469,308
-89,392 Reduced 85.89%
14,681 $75,000
Q4 2018

Feb 15, 2019

BUY
$3.51 - $8.6 $312,425 - $765,486
89,010 Added 590.92%
104,073 $426,000
Q3 2018

Nov 14, 2018

BUY
$5.75 - $8.16 $86,612 - $122,914
15,063 New
15,063 $117,000
Q2 2018

Aug 15, 2018

SELL
$5.27 - $6.21 $93,442 - $110,109
-17,731 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$4.91 - $7.72 $87,059 - $136,883
17,731 New
17,731 $102,000
Q4 2017

Feb 15, 2018

SELL
$4.91 - $7.23 $58,217 - $85,726
-11,857 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$5.4 - $7.41 $64,027 - $87,860
11,857
11,857 $64,000

Others Institutions Holding MESO

About MESOBLAST LTD


  • Ticker MESO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 147,316,000
  • Market Cap $1.2B
  • Description
  • Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...
More about MESO
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.